Optomed’s financial reporting in 2023
Optomed Plc Stock Exchange Release 4 August 2022 at 9.05, Helsinki
Optomed’s financial reporting in 2023
Optomed Plc will release its Financial Statement Bulletin, Half-Year Financial Report and Interim Reports in 2023 as follows:
- Financial Statement Bulletin for 1 January – 31 December 2022, 17 February 2023
- Interim Report for 1 January – 31 March 2023, 5 May 2023
- Half-Year Financial Report for 1 January – 30 June 2023, 4 August 2023
- Interim Report for 1 January – 30 September 2023, 3 November 2023
Annual Report 2022, which includes the company’s financial statements, the report of the Board of Directors, the corporate governance statement and the remuneration report, will be published during the week starting on 27 February 2023 at the latest.
Optomed’s Annual General Meeting is planned to be held on 10 May 2023 in the Helsinki region, Finland. The Board of Directors will convene the meeting separately at a later date.
A shareholder who requests a certain issue belonging to the General Meeting to be included on the agenda of the meeting, is asked to notify the Board of Directors in writing by post Optomed Plc, Yrttipellontie 1, FI-90230 Oulu, Finland no later than 14 March 2023.
Optomed Plc
Further enquiries
Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 55 international patents protecting the technology.